Cyclacel Pharmaceuticals Inc. buy Roth Mkm
Start price
03.05.24
/
50%
€0.22
Target price
03.05.25
€10.21
Performance (%)
-
End price
04.05.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cyclacel Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Roth_Mkm for this prediction
In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target lowered by analysts at Roth Mkm from $21.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for CYCC provided by MarketBeat
In the thread Trading Cyclacel Pharmaceuticals Inc.
Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Roth_Mkm for Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.22
19.12.23
19.12.23
€19.12
19.12.24
19.12.24
-
20.12.24
20.12.24

